Defiance Daily Target 2X Long NVO ETF(NVOX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

NVOX Defiance Daily Target 2X Long NVO ETF

Market Closed 04-24 16:00:00 EDT

12.50

+1.51

+13.74%

盘后12.63

+0.13+1.00%

19:59 EDT

High12.52	Low11.77	Vol1.42M
Open11.89	D1 Closing10.99	Amplitude6.82%
Mkt Cap40.73M	Tradable Cap40.73M	Total Shares3.26M
T/O17.25M	T/O Rate43.67%	Tradable Shares3.26M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"NVOX","market":"US","secType":"STK","nameCN":"Defiance Daily Target 2X Long NVO ETF","latestPrice":12.5,"timestamp":1777060800000,"preClose":10.99,"halted":0,"volume":1422661,"hourTrading":{"tag":"盘后","latestPrice":12.6253,"preClose":12.5,"latestTime":"19:59 EDT","volume":44710,"amount":562241.0552,"timestamp":1777075194775,"change":0.1253,"changeRate":0.010024,"amplitude":0.0128},"delay":0,"changeRate":0.1373976342129208,"floatShares":3258101,"shares":3258101,"eps":0,"marketStatus":"Market Closed","change":1.51,"latestTime":"04-24 16:00:00 EDT","open":11.89,"high":12.52,"low":11.77,"amount":17251369.386608,"amplitude":0.068244,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":2,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1777276800000},"marketStatusCode":7,"adr":0,"exchange":"ARCA","adjPreClose":10.99,"sharesOutstanding":4098101,"nav":10.99,"aum":35806529.99,"bidAskSpread":0,"preHourTrading":{"tag":"盘前","latestPrice":11.8817,"preClose":10.99,"latestTime":"09:29 EDT","volume":109460,"amount":1265436.63012,"timestamp":1777037356416,"change":0.8917,"changeRate":0.081137,"amplitude":0.101911},"postHourTrading":{"tag":"盘后","latestPrice":12.6253,"preClose":12.5,"latestTime":"19:59 EDT","volume":44710,"amount":562241.0552,"timestamp":1777075194775,"change":0.1253,"changeRate":0.010024,"amplitude":0.0128},"volumeRatio":1.8185463412061276,"impliedVol":0.93,"impliedVolPercentile":0.616},"requestUrl":"/m/hq/s/NVOX/wiki","defaultTab":"wiki","newsList":[{"id":"1141827555","title":"Domestic Semaglutide's First Approval Faces Delays as Companies Cite Data Exclusivity Period Following Patent Expiry","url":"https://stock-news.laohu8.com/highlight/detail?id=1141827555","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1141827555?lang=en_us&edition=fundamental","pubTime":"2026-04-25 17:34","pubTimestamp":1777109647,"startTime":"0","endTime":"0","summary":"One month after the core compound patent for Novo Nordisk's (NVO.US) blockbuster weight-loss drug semaglutide expired, no domestic version of semaglutide has yet successfully gained approval. Several...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0154236417.USD","LLY","BK0028","BK0239","BK0188","LU1093756168.USD","IE00BKVL7J92.USD","NVO","NVOH","BK0187","BK4588","IE00BZ1G4Q59.USD","LU1093756325.SGD","BK4007","02566","BK4532","BK4585","000513","BK1161","01513","NVOX","BK4599"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630876778","title":"The Trader: Eli Lilly Is More Than GLP-1 Drugs. The Stock Looks Attractive. -- Barron's","url":"https://stock-news.laohu8.com/highlight/detail?id=2630876778","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630876778?lang=en_us&edition=fundamental","pubTime":"2026-04-25 09:31","pubTimestamp":1777080660,"startTime":"0","endTime":"0","summary":"Eli Lilly's most recent acquisition shows its aspirations beyond weight loss drugs. There's time for investors to get in and buy the stock.Kelonia is known for its \"In vivo CAR-T therapy,\" an intravenous injection that offers a cheaper, faster, and potentially more effective way to fight cancer. The treatment doesn't require the use of a lab dish outside the patient's body, reducing the amount of work and time needed to treat the patient. Kelonia is even trying to solidify the drug's use for autoimmune diseases. The company is pre-revenue, but the multiple-myeloma treatment is in Phase 1 of clinical trials.Eli Lilly stock dropped in immediate reaction to this announcement, a common occurrence for large companies making acquisitions. Shares recovered today, but are down 17% since closing at a record high in November. Analysts have lifted sales and earnings estimates since late 2025, according to FactSet, but investors have taken profits after the stock's rally over the past five years.O","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0882574055.USD","IE00B1XK9C88.USD","LU2028103732.USD","SG9999001440.SGD","LU0238689110.USD","LU1551013342.USD","LU1057294990.SGD","LU2552382215.SGD","LU0266013472.USD","SGXZ99366536.SGD","LU0210536198.USD","LU1988902786.USD","LU1868836914.USD","LU0061475181.USD","BK4578","LU2271345857.HKD","LU2324357040.USD","LU2552382132.HKD","LU0289739699.SGD","LU1061106388.HKD","LU0316494557.USD","LU0787776722.HKD","LU1037948897.HKD","LU1571399168.USD","LU1868837300.USD","LU2237443895.HKD","LU2236285917.USD","LU0158827781.USD","LU2360106947.USD","SG9999015986.USD","BK4583","IE00B3T34201.USD","LU2746668461.USD","LU0640476718.USD","LU2264538146.SGD","LU0198837287.USD","LU2750360641.GBP","LU1720051108.HKD","LU0965509010.AUD","LU1804176565.USD","SGXZ51526630.SGD","SG9999018865.SGD","IE00BKPKM429.USD","LU0683600562.USD","IE00B1BXHZ80.USD","LU2462157665.USD","LU2237443622.USD","LU0385154629.USD","LU1066053197.SGD","BK4581","LU1430594728.SGD","LU2602419157.SGD","LU1093756168.USD","SG9999013999.USD","LU0158827948.USD","SG9999015945.SGD","SG9999018857.SGD","LU0353189680.USD","LU2491050154.USD","LU0471298777.SGD","SG9999014906.USD","ELIS","LU1548497426.USD","LU2242652126.USD","IE00B775H168.HKD","IE00B4R5TH58.HKD","LU0672654240.SGD","LU2417539215.USD","IE00BKVL7J92.USD","LU0456855351.SGD","ELIL","IE00BK4W5L77.USD","GB00BDT5M118.USD","LU0861579265.USD","BK4007","BK4585","LU2237443549.SGD","LU2108987350.USD","LU2242646821.SGD","IE00B4JS1V06.HKD","LU2089283258.USD","IE0004445239.USD","LU2237443978.SGD","LU0417517546.SGD","LU1145028129.USD","LU2023250330.USD","LU0122379950.USD","LU2111349929.HKD","LU2237443465.HKD","IE00BSNM7G36.USD","LU2471134523.USD","LU1366192091.USD","LU0234572021.USD","LU0006306889.USD","LU2756315664.SGD","IE00BJJMRX11.SGD","SG9999015978.USD","IE00BJJMRZ35.SGD","BK4568","IE00BJLML261.HKD","LLYZ","LU0058720904.USD","LU0965508806.USD","LU1037948541.HKD","BK4532","LU2023250504.SGD","LU2112291526.USD","LU0823416689.USD","IE00BJT1NW94.SGD","LU1323610961.USD","BK4550","LU2089984988.USD","LU2106854487.HKD","LU1585245621.USD","LU0965509101.SGD","LU0203202063.USD","IE00BFSS7M15.SGD","IE0002141913.USD","LU1868837136.USD","LU1023059063.AUD","IE0004445015.USD","IE00B7SZLL34.SGD","LU2087621335.USD","LU0964807845.USD","IE00BK4W5M84.HKD","LU0354030438.USD","LU1064131342.USD","LU1280957306.USD","LU2746668974.SGD","LU0708995401.HKD","LU2750360997.AUD","IE00B19Z3581.USD","LU1629891620.HKD","LU1674673691.USD","LU2361044949.HKD","LLY","SG9999001176.SGD","SG9999014914.USD","IE0009355771.USD","LU0079474960.USD","LU0225283273.USD","LU0786609619.USD","SG9999014898.SGD","LU0466842654.USD","LU1066051498.USD","IE0005OL40V9.USD","LU1069344957.HKD","IE00BJJMRY28.SGD","IE00BZ1G4Q59.USD","LU1839511570.USD","LU0820562030.AUD","LU2168564222.USD","LU1674673428.USD","LU2456880835.USD","SG9999017495.SGD","LU1974910355.USD","LU0203201768.USD","LU1814569148.SGD","LU1934455863.HKD","BK4516","IE00B2B36J28.USD","LU2168564149.EUR","BK4144","LU0823434583.USD","LU2471134952.CNY","IE00B19Z3B42.SGD","LU2461242641.AUD","SGXZ57979304.SGD","LU2168563687.JPY","BK4588","LU0965509283.SGD","LU1720051017.SGD","LU0097036916.USD","IE00B7KXQ091.USD","BK4566","LU0689472784.USD","LU0256863811.USD","LLII","LU1127390331.HKD","LU2361045086.USD","LU1291159041.SGD","LU1934455194.USD","BK4533","LU1917777945.USD","IE00BWXC8680.SGD","LU2237443382.USD","LU2168564065.EUR","LU0106261372.USD","LU0432979614.USD","LU0094547139.USD","LU1551013425.SGD","LU1868836591.USD","LU2471134879.HKD","LU1035775433.USD","LU1267930730.SGD","LU1934455277.USD","NVOH","IE00BFTCPJ56.SGD","IE0001KFT4U8.USD","LU0882574139.USD","LU2089284900.SGD","LU2087625088.SGD","SGXZ31699556.SGD","LU0354030511.USD","LU2491050071.SGD","LU2357305700.SGD","LLYX","LU0154236417.USD","LU2471134796.USD","LU2468319806.SGD","LU2168564495.EUR","IE0002270589.USD","LU0234570918.USD","LU0323591593.USD","SG9999001176.USD","LU0109391861.USD","LU0256863902.USD","LU0109394709.USD","LU1712237335.SGD","LU1989771016.USD","LU1623119135.USD","LU2896262040.SGD","LU0114720955.EUR","BK4534","BK4599","SG9999015952.SGD","LU0320765059.SGD","IE00BKDWB100.SGD","LU1868836757.USD","LU2023251221.USD","LU0133085943.USD","NVOX","LU0820561909.HKD","LU2491049909.HKD","SGXZ81514606.USD","LU0320765992.SGD","LU2237438978.USD","BK4139","LU1983299246.USD","IE00BN29S564.USD","LU0868494617.USD","LU0823434740.USD","LU0943347566.SGD","LU1093756325.SGD","LU0096364046.USD","LU2361044865.SGD","LU0889565916.HKD","LU0820561818.USD","LU2213496289.HKD","BK4590","LU2211815571.USD","LU2265009873.SGD","LU0353189763.USD","LU0471298694.HKD","LU2756315318.SGD","SG9999014880.SGD","LU1232071149.USD","LU2552382058.USD","LU2063271972.USD","IE00BFSS8Q28.SGD","LU1778281490.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630824119","title":"Moderately bullish activity in Novo Nordisk with shares up 6.37%","url":"https://stock-news.laohu8.com/highlight/detail?id=2630824119","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630824119?lang=en_us&edition=fundamental","pubTime":"2026-04-25 02:50","pubTimestamp":1777056619,"startTime":"0","endTime":"0","summary":"Moderately bullish activity in Novo Nordisk (NVO), with shares up $2.46, or 6.37%, near $40.98. Options volume running well above average with 108k...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/moderately-bullish-activity-in-novo-nordisk-with-shares-up-6-37-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/moderately-bullish-activity-in-novo-nordisk-with-shares-up-6-37-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NVO","BK4588","LU1093756325.SGD","LU0154236417.USD","BK4007","BK4532","IE00BKVL7J92.USD","NVOH","NVOX","BK4599","LU1093756168.USD","IE00BZ1G4Q59.USD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630710825","title":"Novo Nordisk A/S Stock Rises Friday, Outperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2630710825","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630710825?lang=en_us&edition=fundamental","pubTime":"2026-04-25 00:02","pubTimestamp":1777046520,"startTime":"0","endTime":"0","summary":"This article was automatically generated using Dow Jones technology.Shares of Novo Nordisk A/S rose 5.4% to DKK259.95 Friday on what proved to be an overall poor trading session for the stock market, with the OMX Nordic 40 Index falling 0.4% to 2,583.89.The company closed DKK273.45 short of its 52-week high of DKK533.40, which the company reached on June 13, 2025.Trading volume was 7,344,915, compared to the 50-day average trading volume of 7,409,451.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BKVL7J92.USD","NVOX","LU1093756168.USD","BK4532","LU0154236417.USD","LU1093756325.SGD","BK4585","NVO","NVOH","BK4599","BK4588","IE00BZ1G4Q59.USD","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629237248","title":"European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2629237248","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629237248?lang=en_us&edition=fundamental","pubTime":"2026-04-24 23:23","pubTimestamp":1777044216,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts were rising late Friday morning, gaining 0.66% at 1,798.36 on the S&P Europe Select ADR Index, which is off 2% for the week so far.From continental Europe, the gainers were led by pharmaceutical company Novo Nordisk  and software firm SAP , which rose 6.4% and 5.6% respectively. They were followed by furniture maker Natuzzi  and consumer goods company Unilever , which were up 2.6% and 1.7% respectively.The decliners from continental Europe were led by biotech firm Evaxion  and petroleum refiner Equinor , which fell 2.4% and 1.4% respectively. They were followed by biopharmaceutical company Cellectis  and oil and gas company Eni , which were down 1.2% and 0.9% respectively.The gainers from the UK were led by British American Tobacco  and InterContinental Hotels Group , which advanced 2.5% and 2.4% respectively. They were followed by insurance company Prudential  and educational publisher Pearson , which increased 1.2% an","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BTI","BK4585","BK4532","BK4111","LU1093756168.USD","LU0072461881.USD","BK4107","BK4592","BK4082","BK7104","UL","NVOH","BK4183","IHG","TRIB","BK4117","BK4528","BK4613","BK4162","NTZ","AUTL","SAP","SLN","PSO","BK4075","NCNA","CLLS","UN","E","BK4201","BK4023","BK7062","LU0154236417.USD","IE00BKVL7J92.USD","EQNR","NVOX","BK4588","BK4139","ULVR.UK","BK4599","LU0124676726.USD","BK4142","LU1093756325.SGD","LU2543165471.USD","PUK","BK4007","LU0162691827.USD","BK4095","IE00BZ1G4Q59.USD","LU0006061336.USD","NVO","02378","LU0689626769.HKD","BK4204","EVAX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1119240873","title":"Eli Lilly Shares Decline Over 4% While Novo Nordisk Rises 6%","url":"https://stock-news.laohu8.com/highlight/detail?id=1119240873","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1119240873?lang=en_us&edition=fundamental","pubTime":"2026-04-24 23:01","pubTimestamp":1777042912,"startTime":"0","endTime":"0","summary":"On April 24, Eli Lilly's stock price fell 4.5%, whereas Novo Nordisk's shares climbed by 6%.","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0256863902.USD","GB00BDT5M118.USD","LU2023250330.USD","IE0002141913.USD","IE00B4JS1V06.HKD","LU1127390331.HKD","LU1551013342.USD","LU0471298777.SGD","BK4533","LU2106854487.HKD","LU0432979614.USD","LU0266013472.USD","LU2461242641.AUD","LU0353189763.USD","LU2417539215.USD","LU0238689110.USD","SG9999018865.SGD","IE00BKDWB100.SGD","LU1366192091.USD","SG9999014880.SGD","BK4599","IE00BJJMRZ35.SGD","LU0689472784.USD","BK4532","LU0820562030.AUD","LU1720051108.HKD","BK4534","LU2491049909.HKD","LU2471134879.HKD","LU0096364046.USD","LU0672654240.SGD","LU0316494557.USD","LU2756315318.SGD","LU1917777945.USD","LU2552382058.USD","LU1023059063.AUD","IE00BJLML261.HKD","SG9999017495.SGD","LU0456855351.SGD","IE00BFTCPJ56.SGD","LU0323591593.USD","LU0234572021.USD","IE00B4R5TH58.HKD","LU0640476718.USD","LU2168563687.JPY","LU2324357040.USD","LU1093756325.SGD","LU0203201768.USD","LU0109391861.USD","IE00BJJMRX11.SGD","LU2750360997.AUD","SG9999015952.SGD","LU2211815571.USD","LU2357305700.SGD","LLYZ","LU0094547139.USD","LU0385154629.USD","LU1712237335.SGD","IE0004445015.USD","LU2237443465.HKD","SG9999018857.SGD","LU0006306889.USD","LU2471134796.USD","LU2462157665.USD","SG9999014898.SGD","LU1093756168.USD","LU2271345857.HKD","LU0471298694.HKD","NVOH","LU2028103732.USD","SG9999001176.SGD","LU0109394709.USD","LLII","LU2168564495.EUR","LU1868836757.USD","IE00BK4W5M84.HKD","IE00B2B36J28.USD","LU2237438978.USD","LU0708995401.HKD","NVOX","SG9999015986.USD","SGXZ51526630.SGD","ELIL","LU0097036916.USD","LU2746668974.SGD","SGXZ31699556.SGD","LU2089283258.USD","LU1267930730.SGD","IE0004445239.USD","LU2168564065.EUR","LU2168564222.USD","LU2360106947.USD","LU0320765992.SGD","IE00BKVL7J92.USD","LU1280957306.USD","LU1868837136.USD","LU0198837287.USD","LU0820561909.HKD","LU2023250504.SGD","LU2237443622.USD","LU2237443895.HKD","SGXZ99366536.SGD","LU0079474960.USD","IE0005OL40V9.USD","LU0106261372.USD","LU0354030511.USD","LU0061475181.USD","LU0683600562.USD","LU1548497426.USD","LU2023251221.USD","LU2361044949.HKD","LU0466842654.USD","LU1623119135.USD","LU0353189680.USD","LU2265009873.SGD","IE00BK4W5L77.USD","IE00BFSS8Q28.SGD","LU0225283273.USD","IE00BFSS7M15.SGD","IE00BJJMRY28.SGD","LU0133085943.USD","LU2089984988.USD","LU0158827781.USD","LU2491050071.SGD","LU2237443382.USD","LU2213496289.HKD","LU1629891620.HKD","IE0001KFT4U8.USD","BK4585","LU2456880835.USD","LU0889565916.HKD","SGXZ81514606.USD","IE00BWXC8680.SGD","LU2552382215.SGD","LU0320765059.SGD","LU0820561818.USD","LU1057294990.SGD","SG9999015945.SGD","IE00B1XK9C88.USD","IE00BJT1NW94.SGD","LU1069344957.HKD","LU2063271972.USD","LU2168564149.EUR","LU1868836914.USD","LU2237443978.SGD","LU0882574139.USD","LU1974910355.USD","LU2468319806.SGD","LU0964807845.USD","SG9999001176.USD","BK4588","SG9999014906.USD","LU1064131342.USD","LU2236285917.USD","IE00B7KXQ091.USD","LU0943347566.SGD","LU2471134523.USD","LU1868836591.USD","LU1989771016.USD","LU1983299246.USD","LU2089284900.SGD","LU2111349929.HKD","LU0256863811.USD","LU1061106388.HKD","SG9999014914.USD","LU0114720955.EUR","IE00BKPKM429.USD","LU0289739699.SGD","LU0823416689.USD","LU2602419157.SGD","LU0158827948.USD","LU1868837300.USD","LU2746668461.USD","LU0354030438.USD","LU2552382132.HKD","LU2750360641.GBP","NVO","LU1291159041.SGD","LU0787776722.HKD","LU0210536198.USD","LU0823434740.USD","LU1988902786.USD","LU0823434583.USD","BK4516","IE00BN29S564.USD","LU0122379950.USD","IE0009355771.USD","LU2361044865.SGD","LU1804176565.USD","LU0058720904.USD","LU0882574055.USD","LU2108987350.USD","LU1323610961.USD","SGXZ57979304.SGD","LU1145028129.USD","IE00BZ1G4Q59.USD","LU0203202063.USD","LU0417517546.SGD","BK4581","LU0786609619.USD","LU1814569148.SGD","LU1720051017.SGD","LU1232071149.USD","LU2112291526.USD","LU2896262040.SGD","LU1551013425.SGD","LLY","LU2756315664.SGD","IE00B1BXHZ80.USD","LU2471134952.CNY","ELIS","LU2087625088.SGD","LLYX","BK4007","LU2491050154.USD","LU1035775433.USD","LU2237443549.SGD","LU2264538146.SGD","SG9999015978.USD","IE00B775H168.HKD","LU0154236417.USD","SG9999013999.USD","LU2361045086.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1104793495","title":"Novo Shares Rise 6% While Lilly Falls over 4%. Lilly's New Obesity Pill Off to Slow Start in Race With Novo","url":"https://stock-news.laohu8.com/highlight/detail?id=1104793495","media":"Tiger Newspress","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1104793495?lang=en_us&edition=fundamental","pubTime":"2026-04-24 22:34","pubTimestamp":1777041293,"startTime":"0","endTime":"0","summary":"Eli Lilly & Co.’s new weight-loss pill Foundayo has gotten off to a sluggish start, according to new prescription data, an early sign of the challenge the drugmaker will have as it tries to catch up...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"8f1ae53e4a6b7139d878341ee022303c","theme_name":"TrendingNo.7 · Eli Lilly's Foundayo Faces Slow Start While Novo Nordisk's Oral Weight-Loss Drug Gains Market Lead","theme_type":2,"isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Lilly's New Obesity Pill Off to Slow Start in Race With Novo","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LLYZ","ELIS","NVO","ELIL","NVOX","LLY","NVOH","LLII","LLYX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629828808","title":"Novo Nordisk call volume above normal and directionally bullish","url":"https://stock-news.laohu8.com/highlight/detail?id=2629828808","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629828808?lang=en_us&edition=fundamental","pubTime":"2026-04-24 22:29","pubTimestamp":1777040946,"startTime":"0","endTime":"0","summary":"Bullish option flow detected in Novo Nordisk (NVO) with 36,468 calls trading, 3x expected, and implied vol increasing over 2 points to 50.75%. 5/1 ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/novo-nordisk-call-volume-above-normal-and-directionally-bullish-thefly-news-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/novo-nordisk-call-volume-above-normal-and-directionally-bullish-thefly-news-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4532","BK4585","BK4588","LU0154236417.USD","BK4007","NVOX","NVOH","BK4599","LU1093756168.USD","NVO","IE00BZ1G4Q59.USD","IE00BKVL7J92.USD","LU1093756325.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1106855768","title":"Eli Lilly Stumbles in Oral Weight-Loss Drug Race as Novo Nordisk Takes Early Lead","url":"https://stock-news.laohu8.com/highlight/detail?id=1106855768","media":"Deep News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1106855768?lang=en_us&edition=fundamental","pubTime":"2026-04-24 21:38","pubTimestamp":1777037935,"startTime":"0","endTime":"0","summary":"Eli Lilly's newly launched oral weight-loss drug, Foundayo, has recorded significantly fewer prescriptions in its initial weeks compared to its competitor, raising doubts about its ability to catch...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2756315664.SGD","LU0787776722.HKD","LU2271345857.HKD","LU1064131342.USD","LU2112291526.USD","LU2089984988.USD","LU2237443465.HKD","LU2213496289.HKD","LU2237443895.HKD","LU0466842654.USD","LU0882574055.USD","LU0882574139.USD","LU0417517546.SGD","LU0786609619.USD","LU1720051017.SGD","LU2211815571.USD","IE00B1BXHZ80.USD","IE0005OL40V9.USD","IE0001KFT4U8.USD","LU2023250330.USD","LU0097036916.USD","IE00BKPKM429.USD","SG9999014906.USD","LU2602419157.SGD","IE00BKDWB100.SGD","BK4581","LU1145028129.USD","IE00BKVL7J92.USD","LU2237443549.SGD","LU1712237335.SGD","LU0320765059.SGD","LU2471134796.USD","LU2471134879.HKD","LU0114720955.EUR","LU1548497426.USD","LU2462157665.USD","LU1917777945.USD","LU2023251221.USD","SG9999018857.SGD","LU2237443622.USD","LU0820561818.USD","LU2087625088.SGD","LU1804176565.USD","LU1061106388.HKD","LU1232071149.USD","LU0683600562.USD","LU1629891620.HKD","BK4007","LU1868836757.USD","LU2552382132.HKD","ELIS","IE00B4JS1V06.HKD","LU2111349929.HKD","LU2491050071.SGD","IE00BK4W5L77.USD","LU2552382215.SGD","BK4533","IE0004445015.USD","LU0354030511.USD","SG9999015945.SGD","LU2168564149.EUR","LU0109394709.USD","IE00BK4W5M84.HKD","NVO","LU0471298777.SGD","SGXZ31699556.SGD","LU0708995401.HKD","LU1267930730.SGD","LU2237443978.SGD","LU0058720904.USD","LU2552382058.USD","LU0079474960.USD","LU0823434583.USD","LU2108987350.USD","SG9999013999.USD","LU0320765992.SGD","LU2106854487.HKD","BK4599","LU0109391861.USD","SGXZ99366536.SGD","LU0289739699.SGD","ELIL","LU0061475181.USD","LU1623119135.USD","LU2168564495.EUR","LU0096364046.USD","SG9999014880.SGD","LU0006306889.USD","LU2361045086.USD","SG9999018865.SGD","SG9999015978.USD","LU1868836914.USD","BK4532","LU2456880835.USD","LU1989771016.USD","LU0203201768.USD","LU2756315318.SGD","IE0004445239.USD","IE00BZ1G4Q59.USD","IE00BJJMRX11.SGD","LU2417539215.USD","IE00BN29S564.USD","BK4534","LU0456855351.SGD","LU2746668461.USD","LU2264538146.SGD","LU1974910355.USD","IE00B4R5TH58.HKD","LU2896262040.SGD","LU0203202063.USD","SGXZ51526630.SGD","LU2750360641.GBP","LU2468319806.SGD","LU0256863902.USD","LU0823416689.USD","IE00BJJMRY28.SGD","IE00BWXC8680.SGD","LU0471298694.HKD","IE00BJJMRZ35.SGD","LU0823434740.USD","SG9999017495.SGD","LU0234572021.USD","LLY","LU1988902786.USD","IE00BFSS8Q28.SGD","LU2089283258.USD","LU0385154629.USD","IE0009355771.USD","LU0210536198.USD","LU2491050154.USD","IE00BJLML261.HKD","LU2168563687.JPY","LU0323591593.USD","LU2361044949.HKD","LU0353189763.USD","LU0106261372.USD","IE00B775H168.HKD","LU2168564065.EUR","SG9999001176.SGD","LU0158827948.USD","SGXZ81514606.USD","LU0943347566.SGD","LU0689472784.USD","LU0154236417.USD","SG9999014898.SGD","BK4516","LU1069344957.HKD","LU2089284900.SGD","LU0133085943.USD","SG9999014914.USD","BK4588","IE00B1XK9C88.USD","LU0238689110.USD","LU1814569148.SGD","LU2746668974.SGD","LU0672654240.SGD","LU1093756325.SGD","LU2168564222.USD","LU0964807845.USD","LU0889565916.HKD","LU0122379950.USD","IE00B2B36J28.USD","LU0354030438.USD","LU1093756168.USD","LU1023059063.AUD","LU2063271972.USD","LU1291159041.SGD","LU2023250504.SGD","LU1551013425.SGD","LU2461242641.AUD","LU0820561909.HKD","LLYZ","LLII","LU2471134523.USD","SG9999015986.USD","SGXZ57979304.SGD","LU0094547139.USD","IE00BFSS7M15.SGD","LU1035775433.USD","LU1868836591.USD","LU2265009873.SGD","GB00BDT5M118.USD","LU1280957306.USD","BK4585","LU0198837287.USD","NVOH","LU1720051108.HKD","LU1868837300.USD","LU1057294990.SGD","LU2491049909.HKD","LU0820562030.AUD","LU1127390331.HKD","IE0002141913.USD","LU0256863811.USD","SG9999001176.USD","SG9999015952.SGD","LU0266013472.USD","IE00B7KXQ091.USD","LU2357305700.SGD","LU2237438978.USD","LU2324357040.USD","LU0225283273.USD","LU0316494557.USD","NVOX","IE00BFTCPJ56.SGD","LU2360106947.USD","LU1323610961.USD","LU2471134952.CNY","LU0432979614.USD","LU2236285917.USD","LU0353189680.USD","LU2237443382.USD","LU1983299246.USD","LU2028103732.USD","IE00BJT1NW94.SGD","LU0158827781.USD","LU2750360997.AUD","LU1551013342.USD","LLYX","LU1868837136.USD","LU1366192091.USD","LU0640476718.USD","LU2361044865.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629842492","title":"Novo Nordisk Shares Rise After Positive Oral Semaglutide Trial In Children","url":"https://stock-news.laohu8.com/highlight/detail?id=2629842492","media":"Benzinga_recent_news","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629842492?lang=en_us&edition=fundamental","pubTime":"2026-04-24 21:32","pubTimestamp":1777037520,"startTime":"0","endTime":"0","summary":"Novo Nordisk shares are up on Friday after reporting oral semaglutide trial results in children aged 10-17 years old with type 2 diabetes.","market":"us","thumbnail":"https://cdn.benzinga.com/files/images/story/2026/04/24/Konskie--Poland---January-11--2024-Novo-.jpeg?optimize=medium&dpr=2&auto=webp&width=240","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2026/04/24/Konskie--Poland---January-11--2024-Novo-.jpeg?optimize=medium&dpr=2&auto=webp&width=240"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/trading-ideas/movers/26/04/52028225/novo-nordisk-shares-rise-after-positive-oral-semaglutide-trial-in-children","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/trading-ideas/movers/26/04/52028225/novo-nordisk-shares-rise-after-positive-oral-semaglutide-trial-in-children","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_recent_news","symbols":["NVOX","NVOH","LU1093756325.SGD","NVO","BK4599","IE00BZ1G4Q59.USD","BK4588","LU1093756168.USD","BK4585","BK4532","BK4007","IE00BKVL7J92.USD","LU0154236417.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629885444","title":"Sector Update: Health Care Stocks Lower in Afternoon Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2629885444","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629885444?lang=en_us&edition=fundamental","pubTime":"2026-04-24 01:56","pubTimestamp":1776966983,"startTime":"0","endTime":"0","summary":"Health care stocks declined Thursday afternoon, with the NYSE Health Care Index decreasing 0.5% and the State Street Health Care Select Sector SPDR ETF  shedding 0.7%.The iShares Biotechnology ETF  fell 1.9%.In sector news, Acting Attorney General Todd Blanche signed an order Thursday reclassifying state-licensed medical cannabis as a less-dangerous drug, the Associated Press reported, citing a statement from Blanche.In corporate news, Thermo Fisher Scientific  raised its full-year outlook as Q1 results came in stronger than expected, but organic growth fell short of analysts' estimates. Shares fell 11%.Regeneron Pharmaceuticals  has struck an agreement with the Trump administration to reduce drug costs for certain Americans and has secured approval for a gene therapy to treat a rare form of deafness, Bloomberg reported. Regeneron shares rose 1.6%.Novo Nordisk  said a phase 3a trial of oral semaglutide in children and adolescents aged between 10 and 17 years with type-2 diabetes showed","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE00B19Z8W00.USD","LU2112291526.USD","LU0823434740.USD","LU2362540622.SGD","LU1291159041.SGD","LU1803068623.USD","LU0053666078.USD","LU1923622291.USD","LU2362541273.HKD","LU0096362180.USD","LU1057294990.SGD","IE00BZ1G4Q59.USD","IE00BQXX3F31.USD","BK4535","BK4548","LU2357305700.SGD","LU1923621640.USD","LU1988902786.USD","LU0957791311.USD","IE00BKVL7J92.USD","LU0823416689.USD","IE00B1BXHZ80.USD","REGN","LU2264538146.SGD","LU2764263039.SGD","LU0234572021.USD","LU2125909593.SGD","LU0640476718.USD","BK7104","IE00BJJMRZ35.SGD","LU1791710582.SGD","LU2362541513.USD","LU0882574055.USD","LU2106854487.HKD","IE0002141913.USD","LU1153585028.USD","LU0320765489.SGD","LU0557290698.USD","IE0034235188.USD","LU2237438978.USD","LU1815333072.USD","LU0058720904.USD","LU0289739699.SGD","LU1974910355.USD","IE00BKPKM429.USD","LU1280957306.USD","NVOX","BK4533","LU1854104046.USD","LU1061106388.HKD","IE00B2B36J28.USD","LU0208291251.USD","LU0109394709.USD","GB00BDT5M118.USD","LU2023250504.SGD","LU0114720955.EUR","LU0316494557.USD","IE00B19Z8X17.USD","LU1791710400.SGD","LU1923622614.USD","LU1093756168.USD","LU2468319806.SGD","LU2720916845.USD","BK4581","LU1854103824.USD","LU0122379950.USD","NVO","BK4588","LU1023059063.AUD","LU2092937221.SGD","LU0266013472.USD","LU1093756325.SGD","LU0342679015.USD","LU1720051017.SGD","LU2211814178.USD","IE00BFTCPJ56.SGD","BK4007","LU1670628061.USD","IE0009355771.USD","LU2298321311.HKD","LU2360108059.USD","LU2041044095.USD","LU0320765992.SGD","BK4585","LU1983299246.USD","BK4534","XLV","LU0011850046.USD","LU0528227936.USD","LU1720051108.HKD","LU2764263203.CNY","LU1917777945.USD","LU0061474960.USD","BK4566","LU0070302665.USD","LU0823434583.USD","LU1712237335.SGD","LU2063271972.USD","LU2433249047.HKD","LABU","LU2089984988.USD","LU1548497426.USD","LU0345770308.USD","LU2125910336.SGD","BK4139","LU1670627923.USD","LU2125909247.SGD","LU2125910179.SGD","XBI","TMO","NVOH","LU2125909759.SGD","BK4121","IE00BQXX3C00.GBP","LU0889565916.HKD","LU1633808545.USD","LU0154236417.USD","BK4599","LU2764262908.HKD","LU0345770993.USD","IE00B4R5TH58.HKD","LU1989771016.USD","LU2211815571.USD","LU1623119135.USD","LU2543165471.USD","IE00B19Z9505.USD","IBB","LU1064131342.USD","LU2125909916.SGD","BK4532","IE00BQXX3D17.EUR","IE00BJT1NW94.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629518638","title":"This Pharma Stock Is Soaring After Earnings. It's a Sneaky GLP-1 Play. -- Barrons.com","url":"https://stock-news.laohu8.com/highlight/detail?id=2629518638","media":"Dow Jones","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629518638?lang=en_us&edition=fundamental","pubTime":"2026-04-24 00:47","pubTimestamp":1776962820,"startTime":"0","endTime":"0","summary":"You already know the big names in weight-loss drugs: Eli Lilly, Novo Nordisk, Hims & Hers Health. A lesser-known stock was making moves Thursday.Shares of West Pharmaceutical Services soared after the maker of injectable components reported better-than-expected quarterly results. The company posted adjusted earnings of $2.13 a share for the first quarter, up from $1.45 a year ago and ahead of Wall Street's call for $1.68. Revenue jumped 21% from last year to $844.9 million, above analysts' consensus estimate of $780.3 million.West Pharmaceutical stock surged 13%, bringing the stock into the black for the year. Shares have gained 48% over the past 12 months.The company boosted its 2026 guidance in light of the earnings beat. It now expects adjusted earnings per share of $8.40 to $8.75, up from the previous range of $7.85 to $8.20. Revenue should total $3.295 billion to $3.35 billion, the company projected, up from an earlier forecast of $3.215 billion to $3.275 billion.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":"This Pharma Stock Is Soaring After Earnings. It's a Sneaky GLP-1 Play. -- Barrons.com","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4144","LU0096364046.USD","LU0097036916.USD","LU0154236417.USD","LU2213496289.HKD","LU2471134523.USD","HIMZ","IE00BJT1NW94.SGD","LU0266013472.USD","LU0234572021.USD","LU2028103732.USD","LU1057294990.SGD","SG9999018865.SGD","IE00BZ1G4Q59.USD","LU1035775433.USD","LU2552382058.USD","SG9999014880.SGD","LU0345774391.USD","LU2168564222.USD","LU2491050071.SGD","BK4534","IE00BK4W5L77.USD","LU2236285917.USD","BK4516","LU1291159041.SGD","HMYY","LU1145028129.USD","LU0323591593.USD","SGXZ51526630.SGD","LU0320765992.SGD","LU1720051108.HKD","SG9999014914.USD","LU2237443382.USD","IE00BJJMRY28.SGD","SG9999001176.SGD","LU0106261372.USD","IE00B2B36J28.USD","LU2023250330.USD","LU2756315664.SGD","IE00BJJMRZ35.SGD","LU1093756325.SGD","WST","SG9999015945.SGD","LU2746668461.USD","LU0238689110.USD","LU0316494557.USD","LU0683600562.USD","IE0005OL40V9.USD","SG9999015986.USD","LU1814569148.SGD","IE00BFSS7M15.SGD","LU1064131342.USD","LU2089984988.USD","GB00BDT5M118.USD","LU0114720955.EUR","LU0964807845.USD","LU0061475181.USD","LU0256863811.USD","LU0820562030.AUD","LU2471134796.USD","LU1983299246.USD","LU2087625088.SGD","LU0256863902.USD","LU0889565916.HKD","LU0289739699.SGD","BK4533","LU1551013425.SGD","LU0122379950.USD","LU2324357040.USD","LU2491049909.HKD","BK4196","LU1868836757.USD","LU2357305700.SGD","LU2456880835.USD","LLYX","LU0203201768.USD","LU1127390331.HKD","IE00BFTCPJ56.SGD","LU2112291526.USD","LU2417539215.USD","LU2361044865.SGD","LU1988902786.USD","LU0823416689.USD","LU1804176565.USD","LU2468319806.SGD","SGXZ81514606.USD","IE0002141913.USD","LU2106854487.HKD","LU0432979614.USD","LU0823434583.USD","SG9999015978.USD","LU0823434740.USD","LU0385154629.USD","LU0466842654.USD","LU1868837300.USD","SG9999014906.USD","LU0225283273.USD","LU0820561909.HKD","LU2237443549.SGD","ELIS","IE00BKVL7J92.USD","LU0006306889.USD","LU2746668974.SGD","LU2063271972.USD","LU2237438978.USD","LU2361045086.USD","IE00B64QTZ34.USD","IE0004445015.USD","LU0094547139.USD","LU2237443465.HKD","LU2237443622.USD","LU0133085943.USD","LU2750360641.GBP","BK4567","LU0471298777.SGD","LU2089283258.USD","LU2271345857.HKD","LU1551013342.USD","BK4588","LU2471134879.HKD","LU2111349929.HKD","LU0158827948.USD","IE00B7KXQ091.USD","LU2552382132.HKD","SG9999017495.SGD","IE00BFSS8Q28.SGD","LU2491050154.USD","LU1868836914.USD","LU2108987350.USD","LU2552382215.SGD","IE00BK4W5M84.HKD","SGXZ57979304.SGD","IE00BJLML261.HKD","BK4585","IE00B775H168.HKD","BK4590","LU0417517546.SGD","HIYY","IE00BKDWB100.SGD","BK4007","LU2023250504.SGD","LU2023251221.USD","LU0203202063.USD","IE0009355771.USD","LU0689472784.USD","LU1712237335.SGD","IE00B1BXHZ80.USD","IE00BFXG0V08.USD","LU0158827781.USD","LU1232071149.USD","LU1974910355.USD","LU0353189680.USD","BK4504","LLYZ","LU0106261612.USD","LU2756315318.SGD","IE00BJJMRX11.SGD","LU1868836591.USD","BK4599","LU1917777945.USD","LU1280957306.USD","LU2361044949.HKD","LU2896262040.SGD","LU1623119135.USD","LU0198837287.USD","SG9999014898.SGD","SG9999013999.USD","LU0320765059.SGD","LU0943347566.SGD","LU1069344957.HKD","LU0210536198.USD","LU0882574055.USD","LU2237443895.HKD","LU0882574139.USD","LU2750360997.AUD","LU2264538146.SGD","LU1023059063.AUD","LU1366192091.USD","IE00BKPKM429.USD","SG9999001176.USD","LU2237443978.SGD","LU0079474960.USD","LU2360106947.USD","LU0354030438.USD","LU0672654240.SGD","SG9999018857.SGD","LU0640476718.USD","LU0109394709.USD","LU2168564065.EUR","IE00BN29S564.USD","LU0471298694.HKD","LU2461242641.AUD","LU2168564149.EUR","ELIL","LU1548497426.USD","LU0787776722.HKD","NVOH","HIMY","LU0820561818.USD","BK4581","LU2265009873.SGD","LU2471134952.CNY","BK4532","LU0353189763.USD","IE00B4R5TH58.HKD","LU1868837136.USD","LU2089284900.SGD","LU2168564495.EUR","LU2462157665.USD","SGXZ31699556.SGD","LU2211815571.USD","LU1093756168.USD","LU1267930730.SGD","LU2602419157.SGD","LU0708995401.HKD","SGXZ99366536.SGD","LU1061106388.HKD","BK4121","LU0456855351.SGD","LU0058720904.USD","LU0786609619.USD","LLII","IE0004445239.USD","LU0345774631.USD","LU1720051017.SGD","LU0354030511.USD","LU2168563687.JPY","LU1989771016.USD","IE00BYQQ9H92.USD","IE00BWXC8680.SGD","NVOX","LU0012050646.USD","IE00B1XK9C88.USD","LU1629891620.HKD","IE00B4JS1V06.HKD","SG9999015952.SGD","LU1323610961.USD","LU0109391861.USD","IE0001KFT4U8.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629597048","title":"Novo Nordisk Completes Key CagriSema vs. Tirzepatide Diabetes Trial: What Investors Should Watch","url":"https://stock-news.laohu8.com/highlight/detail?id=2629597048","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629597048?lang=en_us&edition=fundamental","pubTime":"2026-04-24 00:31","pubTimestamp":1776961913,"startTime":"0","endTime":"0","summary":"Novo Nordisk ($NVO) announced an update on their ongoing clinical study. Novo Nordisk’s phase 3 trial NCT06221969, officially titled “Efficacy and ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/novo-nordisk-completes-key-cagrisema-vs-tirzepatide-diabetes-trial-what-investors-should-watch?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/novo-nordisk-completes-key-cagrisema-vs-tirzepatide-diabetes-trial-what-investors-should-watch?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","LU1093756168.USD","BK4599","BK4211","NVOH","BK4588","NVOX","IE00BZ1G4Q59.USD","LU0154236417.USD","LU1093756325.SGD","IE00BKVL7J92.USD","BK4585","NVO","BK4532"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629536708","title":"Hims Yields Ground in GLP-1 Market. Why Its CEO Is Calling It the Netflix of Pharma. -- Barrons.com","url":"https://stock-news.laohu8.com/highlight/detail?id=2629536708","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629536708?lang=en_us&edition=fundamental","pubTime":"2026-04-23 22:43","pubTimestamp":1776955380,"startTime":"0","endTime":"0","summary":"Hims & Hers Health is losing its edge as major drugmakers move to reclaim market share the telehealth provider gained during a shortage in GLP-1 medications.Eli Lilly was the latest to receive a concession on Thursday, as CEO Andrew Dudum said Hims would allow providers on its platform to prescribe scripts filled by independent pharmacies, namely LillyDirect.With the announcement, Hims now carries a \"full range of FDA-approved GLP-1s,\" the company said. The latest offering is part of a subscription-based model bundling clinical support with nutrition guidance.At the same time, \"it is hard to tell what role Hims is playing here beyond being the front door to patients accessing Lilly products,\" the analyst continued. He noted the announcement follows the company's step away from large-scale compounding and its decision to yield to Novo Nordisk, Lilly's rival in GLP-1 drugs.Hims enjoyed a surge in popularity in late 2024 amid a shortage of GLP-1 medications, as enormous demand created an ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1989771016.USD","LU0109391861.USD","BK4532","SGXZ51526630.SGD","LU0417517546.SGD","NVO","IE00BK4W5L77.USD","LU1983299246.USD","HIYY","LU1974910355.USD","LU2756315318.SGD","SG9999015986.USD","LU0320765992.SGD","LU1093756325.SGD","LU0114720955.EUR","LU2089284900.SGD","LU1988902786.USD","ELIS","IE00BKPKM429.USD","LU2112291526.USD","LU0316494557.USD","LU1035775433.USD","LU2236285917.USD","LU2237443895.HKD","LU0466842654.USD","LU0820562030.AUD","LU2461242641.AUD","IE00BFSS8Q28.SGD","IE0004445015.USD","LU2756315664.SGD","LU0289739699.SGD","LU0225283273.USD","HIMZ","LU0203202063.USD","BK4516","LU2087625088.SGD","LU0238689110.USD","LU0058720904.USD","LU0198837287.USD","LU0456855351.SGD","HIMY","LU2357305700.SGD","SG9999015952.SGD","LU2471134523.USD","LU0353189763.USD","LU2264538146.SGD","LU0109394709.USD","BK4581","LU1868836914.USD","LU1291159041.SGD","LU0820561818.USD","LU2168564149.EUR","LU2237443978.SGD","HMYY","IE00BJLML261.HKD","BK4007","IE00BJJMRZ35.SGD","LU0256863811.USD","LU1057294990.SGD","LU2361044865.SGD","SGXZ57979304.SGD","SG9999014898.SGD","LU0385154629.USD","LU1064131342.USD","LU1023059063.AUD","LU2896262040.SGD","LU0471298777.SGD","LU0689472784.USD","LU2471134796.USD","LU2106854487.HKD","LU2491050154.USD","IE00B7KXQ091.USD","BK4599","IE00BN29S564.USD","LU0889565916.HKD","LU0708995401.HKD","LU1093756168.USD","LU2552382215.SGD","NVOX","LU1917777945.USD","IE00BZ1G4Q59.USD","IE0001KFT4U8.USD","LU2361045086.USD","LU1232071149.USD","LLYX","LU1804176565.USD","IE00B4R5TH58.HKD","IE00B775H168.HKD","SGXZ81514606.USD","LU2028103732.USD","LU2089283258.USD","LU2750360997.AUD","LU0097036916.USD","SG9999001176.USD","LU2746668974.SGD","IE00BFTCPJ56.SGD","IE0004445239.USD","SG9999014914.USD","SGXZ31699556.SGD","IE0002141913.USD","BK4590","LU0323591593.USD","LU2417539215.USD","LU2237443382.USD","SG9999015945.SGD","IE00B1XK9C88.USD","IE00B2B36J28.USD","LU0882574139.USD","LU0079474960.USD","LU2237443622.USD","SG9999001176.SGD","LU1145028129.USD","LU0823416689.USD","LU1127390331.HKD","LU2552382132.HKD","SG9999014906.USD","LU0882574055.USD","LU2468319806.SGD","LLYZ","LU2168564222.USD","LU2237443549.SGD","LU0210536198.USD","LU0354030511.USD","BK4534","LU2456880835.USD","ELIL","LU0266013472.USD","LU2360106947.USD","SG9999014880.SGD","LU0006306889.USD","LU1366192091.USD","LU2168564065.EUR","LLII","LU0234572021.USD","LU2324357040.USD","LU2108987350.USD","LU2491050071.SGD","LU1720051108.HKD","LU1868836591.USD","LU2089984988.USD","GB00BDT5M118.USD","LU1548497426.USD","LU0106261372.USD","LU0122379950.USD","LU2552382058.USD","LU1868836757.USD","LU0096364046.USD","LU0823434740.USD","LU1623119135.USD","LU1712237335.SGD","LU0820561909.HKD","IE00BKDWB100.SGD","LU2211815571.USD","LU1551013342.USD","BK4588","IE0005OL40V9.USD","LU0354030438.USD","NVOH","LU0640476718.USD","LU1267930730.SGD","LU2237438978.USD","LU2746668461.USD","LU0353189680.USD","LU0158827948.USD","LU2271345857.HKD","BK4144","LU0203201768.USD","LU0943347566.SGD","SG9999018865.SGD","LU0432979614.USD","IE00BK4W5M84.HKD","HIMS","LU0256863902.USD","LU1868837136.USD","IE00BJJMRY28.SGD","LU2023250504.SGD","LU2168563687.JPY","IE00B1BXHZ80.USD","LU0320765059.SGD","LU2023250330.USD","LU2471134879.HKD","LU2750360641.GBP","LU1814569148.SGD","LU2237443465.HKD","LU2491049909.HKD","IE00B4JS1V06.HKD","BK4585","LU2168564495.EUR","LU1069344957.HKD","LU1629891620.HKD","LU1868837300.USD","LU0672654240.SGD","LU0158827781.USD","LU0786609619.USD","IE00BFSS7M15.SGD","SG9999017495.SGD","LU2602419157.SGD","IE00BKVL7J92.USD","BK4196","LU2462157665.USD","SG9999015978.USD","LU2361044949.HKD","LU0154236417.USD","LU2213496289.HKD","LU1551013425.SGD","LU2471134952.CNY","LU0061475181.USD","LU1323610961.USD","LU2111349929.HKD","LU2265009873.SGD","LU0787776722.HKD","SG9999013999.USD","IE00BJT1NW94.SGD","SGXZ99366536.SGD","LU2063271972.USD","LU0471298694.HKD","IE0009355771.USD","LU0823434583.USD","LU0683600562.USD","LU2023251221.USD","IE00BWXC8680.SGD","LU1061106388.HKD","LU1280957306.USD","LU1720051017.SGD","SG9999018857.SGD","IE00BJJMRX11.SGD","LU0133085943.USD","LU0094547139.USD","BK4533","LLY","LU0964807845.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1170047266","title":"Novo Nordisk's Oral GLP-1 Drug Meets Primary Goal in Adolescent Trial, Plans New Indication Filing for H2 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=1170047266","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1170047266?lang=en_us&edition=fundamental","pubTime":"2026-04-23 19:45","pubTimestamp":1776944741,"startTime":"0","endTime":"0","summary":"Novo Nordisk A/S (NVO.US) announced on Thursday that its oral GLP-1 drug significantly reduced blood sugar levels in children and adolescents with type 2 diabetes, achieving the primary objective of...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1093756325.SGD","BK4007","LU0154236417.USD","BK4588","NVOH","BK4599","BK4144","LU1093756168.USD","NVOX","BK4532","BK4585","NVO","IE00BZ1G4Q59.USD","IE00BKVL7J92.USD","BK4590"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629388707","title":"Novo Nordisk Says Oral Semaglutide Trial in Children, Adolescents Shows 'Superior Reduction' in Blood Sugar","url":"https://stock-news.laohu8.com/highlight/detail?id=2629388707","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629388707?lang=en_us&edition=fundamental","pubTime":"2026-04-23 18:24","pubTimestamp":1776939845,"startTime":"0","endTime":"0","summary":"Novo Nordisk  said Thursday a phase 3a trial of oral semaglutide in children and adolescents aged between 10 and 17 years with type-2 diabetes showed a \"superior reduction\" in a measure of blood sugar control over placebo.Results also showed a \"well-tolerated\" safety profile, consistent with prior semaglutide trials, the Danish drugmaker said.Oral semaglutide is available as Rybelsus in the European Union and the US, and will be available in the US as Ozempic pill \"soon,\" Novo Nordisk said.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["NVO","LU1093756325.SGD","BK4588","BK4599","NVOH","BK4532","BK4585","BK7104","LU1093756168.USD","LU0154236417.USD","NVOX","IE00BZ1G4Q59.USD","IE00BKVL7J92.USD","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629202419","title":"Is Novo Nordisk (NYSE:NVO) Price Weakness Creating A Potential Valuation Opportunity?","url":"https://stock-news.laohu8.com/highlight/detail?id=2629202419","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629202419?lang=en_us&edition=fundamental","pubTime":"2026-04-23 02:11","pubTimestamp":1776881512,"startTime":"0","endTime":"0","summary":"If you are wondering whether Novo Nordisk's current share price reflects its true worth, the recent performance gives you plenty to think about.\nThe stock last closed at US$39.42, with returns of 0.3% over 7 days and 7.9% over 30 days, but declines of 24.8% year to date and 32.0% over the past year, setting up a very mixed picture.\nThese moves have arrived as investors continue to reassess large pharmaceutical names and focus more on valuations and pipelines. Novo Nordisk is frequently at...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-nvo/novo-nordisk/news/is-novo-nordisk-nysenvo-price-weakness-creating-a-potential","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-nvo/novo-nordisk/news/is-novo-nordisk-nysenvo-price-weakness-creating-a-potential","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4599","LU1093756325.SGD","IE00BKVL7J92.USD","BK4532","BK4585","BK4588","NVOH","LU1093756168.USD","NVOX","IE00BZ1G4Q59.USD","NVO","BK4007","LU0154236417.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629428025","title":"Novo Nordisk A/S Stock Rises Wednesday, Outperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2629428025","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629428025?lang=en_us&edition=fundamental","pubTime":"2026-04-23 00:02","pubTimestamp":1776873720,"startTime":"0","endTime":"0","summary":"This article was automatically generated using Dow Jones technology.Shares of Novo Nordisk A/S rose 0.8% to DKK249.00 Wednesday on what proved to be an overall unfavorable trading session for the stock market, with the OMX Nordic 40 Index falling 0.2% to 2,593.60.The stock's rise  snapped a two-day losing streak.The company closed DKK284.40 below its 52-week high of DKK533.40, which the company reached on June 13, 2025.Trading volume was 5,401,301, compared to the 50-day average trading volume of 7,752,097.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4599","LU0154236417.USD","BK4588","BK4532","BK4585","IE00BZ1G4Q59.USD","LU1093756325.SGD","NVOH","BK4007","NVOX","IE00BKVL7J92.USD","NVO","LU1093756168.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629010785","title":"Novo Nordisk (0QIU) Gets a Hold from Deutsche Bank","url":"https://stock-news.laohu8.com/highlight/detail?id=2629010785","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629010785?lang=en_us&edition=fundamental","pubTime":"2026-04-22 18:59","pubTimestamp":1776855545,"startTime":"0","endTime":"0","summary":"In a report released today, Emmanuel Papadakis from Deutsche Bank maintained a Hold rating on Novo Nordisk, with a price target of DKK275.00. Papad...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/novo-nordisk-0qiu-gets-a-hold-from-deutsche-bank-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/novo-nordisk-0qiu-gets-a-hold-from-deutsche-bank-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00BZ1G4Q59.USD","LU1093756325.SGD","IE00BKVL7J92.USD","BK4585","LU0154236417.USD","LU1093756168.USD","BK4118","NVOX","BK4599","BK4532","NVO","BK4566","BK4552","BK4588","BK4007","NVOH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629602380","title":"Kepler Capital  Remains a Hold on Novo Nordisk (0QIU)","url":"https://stock-news.laohu8.com/highlight/detail?id=2629602380","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629602380?lang=en_us&edition=fundamental","pubTime":"2026-04-22 09:50","pubTimestamp":1776822616,"startTime":"0","endTime":"0","summary":"Kepler Capital analyst Nicolas Pauillac maintained a Hold rating on Novo Nordisk on April 20 and set a price target of DKK280.00. The company’s sha...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/kepler-capital-remains-a-hold-on-novo-nordisk-0qiu-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/kepler-capital-remains-a-hold-on-novo-nordisk-0qiu-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","LU0154236417.USD","NVOX","NVOH","BK4599","LU1093756168.USD","NVO","BK4585","IE00BKVL7J92.USD","LU1093756325.SGD","BK4007","IE00BZ1G4Q59.USD","BK4532"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":0.0263},{"period":"1month","weight":0.3172},{"period":"3month","weight":-0.6065},{"period":"6month","weight":-0.5055},{"period":"1year","weight":-0.7195},{"period":"ytd","weight":-0.429}],"compareEarnings":[{"period":"1week","weight":0.0054},{"period":"1month","weight":0.087},{"period":"3month","weight":0.0359},{"period":"6month","weight":0.0542},{"period":"1year","weight":0.3059},{"period":"ytd","weight":0.047}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"exchange":"ARCA","name":"Defiance Daily Target 2X Long NVO ETF","nameEN":"Defiance Daily Target 2X Long NVO ETF"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Defiance Daily Target 2X Long NVO ETF(NVOX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Defiance Daily Target 2X Long NVO ETF(NVOX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Defiance Daily Target 2X Long NVO ETF,NVOX,Defiance Daily Target 2X Long NVO ETF股票,Defiance Daily Target 2X Long NVO ETF股票老虎,Defiance Daily Target 2X Long NVO ETF股票老虎国际,Defiance Daily Target 2X Long NVO ETF行情,Defiance Daily Target 2X Long NVO ETF股票行情,Defiance Daily Target 2X Long NVO ETF股价,Defiance Daily Target 2X Long NVO ETF股市,Defiance Daily Target 2X Long NVO ETF股票价格,Defiance Daily Target 2X Long NVO ETF股票交易,Defiance Daily Target 2X Long NVO ETF股票购买,Defiance Daily Target 2X Long NVO ETF股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Defiance Daily Target 2X Long NVO ETF(NVOX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Defiance Daily Target 2X Long NVO ETF(NVOX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}